Literature DB >> 1152772

Sodium restriction and thiazide diuretics in the treatment of hypertension.

S Carney, T Morgan, M Wilson, G Matthews, R Roberts.   

Abstract

In a group of hypertensive patients it has been shown that moderate sodium chloride restriction has a hypotensive effect that is similar to that produced by thiazide diuretics. Blood pressure changed in relation to body weight in individual patients, and appeared to correlate with their sodium balance. The more a patient was depleted of sodium, the lower was the blood pressure. The serum potassium level fell with the use of thiazide diuretics, but in this group of patients there was little change in total body potassium content. The fall in serum potassium level appeared to relate to a shift into the cells due to the accompanying alkalosis. Potassium supplementation appeared to have had little effect and was unnecessary for most patients who were given diuretics for hypertension. Amiloride corrected the alkalosis and restored the serum potassium level to normal.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1152772     DOI: 10.5694/j.1326-5377.1975.tb82051.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  5 in total

1.  By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction.

Authors:  M R Law; C D Frost; N J Wald
Journal:  BMJ       Date:  1991-04-06

2.  Current views on diruetics: their action and use.

Authors:  T O Morgan
Journal:  Drugs       Date:  1975       Impact factor: 9.546

3.  Effect of tienilic acid and amiloride in healthy volunteers and in hypertensives with normal renal function.

Authors:  J B Myers; A Gillies; S Waga; T O Morgan
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

4.  Potassium replacement: supplements or potassium-sparing diuretics?

Authors:  T O Morgan
Journal:  Drugs       Date:  1979-09       Impact factor: 9.546

5.  Low salt diet and frusemide in the treatment of hypertension.

Authors:  C R George; A M Burke
Journal:  Postgrad Med J       Date:  1980-01       Impact factor: 2.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.